End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
283,500 KRW | -4.22% | -1.73% | -19.57% |
May. 16 | Hanmi Pharm. Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 08 | Invion Partners with Hanlim Pharma for Glioblastoma Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.57% | 2.72B | |
+20.14% | 43.3B | |
+24.86% | 22.22B | |
+16.89% | 15.43B | |
+23.10% | 14.48B | |
+57.58% | 12.72B | |
-0.05% | 6.79B | |
-11.86% | 6.71B | |
-8.87% | 5.73B | |
+12.71% | 5.5B |
- Stock Market
- Equities
- A128940 Stock
- News Hanmi Pharm. Co., Ltd.
- Hanmi Pharm Q1 Profit Surges 27.5%, Sales Up 11.8%